Zevra Therapeutics (ZVRA) Net Margin (QoQ) (2019 - 2026)

Zevra Therapeutics (ZVRA) Net Margin (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Zevra Therapeutics 239.71 Mn 39.10 Mn 34.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6,901.00
Dec 31, 2025 3,769.00
Sep 30, 2025 -29,074.00
Jun 30, 2025 30,385.00
Mar 31, 2025 28,234.00
Dec 31, 2024 60,166.00
Sep 30, 2024 -44,635.00
Jun 30, 2024 3,247.00
Mar 31, 2024 -33,135.00
Dec 31, 2023 20,414.00
Sep 30, 2023 -32,772.00
Jun 30, 2023 34,012.00
Mar 31, 2023 7,564.00
Dec 31, 2022 -20,565.00
Sep 30, 2022 167,979.00
Dec 31, 2021 -1,517.00
Sep 30, 2021 -29.00
Jun 30, 2021 30,476.00
Mar 31, 2021 -18,875.00
Dec 31, 2020 -4,893.00